Method for producing retinoid from microorganism
09834794 ยท 2017-12-05
Assignee
Inventors
- Seon Won Kim (Gyeongsangnam-do, KR)
- Hui Jeong Jang (Gyeongsangnam-do, KR)
- Sang Hwal Yoon (Chungcheongnam-do, KR)
- Bo Kyung Ha (Gyeongsangnam-do, KR)
- Hee Kyung Ryu (Gyeongsangnam-do, KR)
Cpc classification
C12N1/38
CHEMISTRY; METALLURGY
C12P5/007
CHEMISTRY; METALLURGY
C12N15/70
CHEMISTRY; METALLURGY
C12P7/40
CHEMISTRY; METALLURGY
International classification
C12N15/70
CHEMISTRY; METALLURGY
C12P5/00
CHEMISTRY; METALLURGY
C12P7/40
CHEMISTRY; METALLURGY
C12N1/38
CHEMISTRY; METALLURGY
Abstract
The present invention relates to a method for producing retinoid from a microorganism, and more specifically, to a method for effectively obtaining retinoid, which lacks stability, from a microorganism by cultivating the microorganism capable of producing retinoid in a medium containing a lipophilic substance, and separating retinoid from the lipophilic substance.
Claims
1. A method for production of retinoid from a microorganism, comprising: culturing a microorganism having retinoid producing efficacy through 2-C-methyl-d-erythritol 4-phosphate (MEP) pathway or mevalonate (MVA) pathway in a medium containing a lipophilic substance; and isolating said retinoid from said lipophilic substance without degrading a cell wall of said microorganism.
2. The method of claim 1, wherein the microorganism is a bacteria, a fungi, a isolated animal cell, or a combination thereof.
3. The method of claim 1, wherein said microorganism is of the genus Escherichia, the genus Bacillus, the genus Corynebacterium, yeast, the genus Kluyveromyces or a combination thereof.
4. The method of claim 1, wherein said lipophilic substance is an alkane compound having 8 to 50 carbon atoms, a compound represented by Formula 1 below, a compound represented by Formula 2 below, or a combination thereof:
R.sub.1(CO)OR.sub.2[Formula 1] wherein R.sub.1 and R.sub.2 are each independently alkyl having 8 to 50 carbon atoms, and CO represents a carbonyl group; and ##STR00002## wherein R.sub.3, R.sub.4 and R.sub.5 are each independently alkyl having 8 to 50 carbon atoms, and CO represents a carbonyl group.
5. The method of claim 1, wherein said lipophilic substance is octane, decane, dodecane, tetradecane, phytosqualane, mineral oil, isopropyl myristate, cetyl ethylhexanoate, dioctanoyl decanoyl glycerol, squalane, or a combination thereof.
6. The method of claim 1, wherein a ratio by volume of said medium to said lipophilic substance ranges from 1:0.2 to 3.0.
7. The method of claim 1, wherein said culturing is performed while agitating.
8. The method of claim 1, wherein said medium further comprises glycerol.
9. The method of claim 1, wherein said medium further comprises glucose.
10. The method of claim 1, wherein said isolating includes removing cells from a culture solution and then isolating said retinoid from dodecane.
11. The method of claim 1, wherein said retinoid is selected from the group consisting of retinal, retinol, retinyl ester and retinoic acid.
12. The method of claim 1, wherein said microorganism is Escherichia coli.
13. The method of claim 12, wherein said Escherichia coli is DH5, MG1655, BL21 (DE), S17-1, XL1-Blue, BW25113 or a combination thereof.
14. The method of claim 1, wherein said microorganism is further transformed with a gene selected from the group consisting of: a gene encoding 3-carotene monooxygenase comprising the amino acid sequence of SEQ ID NO: 13 from uncultured marine bacterium 66A03; a gene encoding -carotene 15,15-monooxygenase comprising the amino acid sequence of SEQ ID NO: 14 from Mus musculus; a gene encoding brp-like protein 2 (brp 2) comprising the amino acid sequence of SEQ ID NO: 15 from Natronomonas pharaonis ATCC35678; and a gene encoding 3-carotene monooxygenase comprising the amino acid sequence of SEQ ID NO: 16 or 17 from Halobacterium salinarum ATCC700922.
15. The method of claim 1, wherein said microorganism is further transformed by a gene comprising the nucleotide sequence of SEQ ID NO: 32, wherein said gene is codon optimized for Escherichia coli.
16. The method of claim 1, wherein said microorganism is further transformed by a gene encoding 1-deoxyxylolose-5-phosphate (DXP) synthase comprising the amino acid sequence of SEQ ID NO: 11 from Escherichia coli.
17. The method of claim 1, wherein said microorganism is further transformed by a gene encoding IPP isomerase comprising the amino acid sequence of SEQ ID NO: 12 from Haematococcus pluvialis.
18. The method of claim 1, wherein said microorganism is Escherichia coli DH5/pTDHB/pSNA deposited under Accession No. KCTC 11254BP or Escherichia coli DH5/pTDHBSR/pSNA deposited under Accession No. KCTC 11255BP.
19. The method of claim 1, wherein said microorganism is of the genus Escherichia.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
DETAILED DESCRIPTION
(21) Hereinafter, the present invention will be described in more details according to the following examples. However, these examples are proposed for illustrative purposes only and the scope of the present invention is not particularly limited thereto. In the examples, the following experimental materials and methods have been used.
(22) Bacteria Strain and Culture Conditions
(23) Escherichia coli DH5 was used for gene cloning and retinoid production. Alternatively, Escherichia coli MG1655, BL21 (DE3), XL1-Blue, S17-1 and BW25113 were used to investigate an optimum strain for retinol production. The culture for retinoid production was executed in a 2YT medium (including 16 g of tryptone, 10 g of yeast extract and 5 g of NaCl per liter) at 29 C. using an agitation incubator operating at 250 rpm. A major and additional carbon sources were glycerol and arabinose, which were added in concentrations of 0.5 to 2% (w/v) and 0.2% (w/v), respectively, to the incubator. Alternative carbon sources for retinoid production, for example, glucose, galactose, xylose and maltose were compared to glycerol. Ampicillin (100 g/mL) and chloramphenicol (50 g/mL) were optionally added to a culture solution requiring the same. The culturing was conducted in a test tube containing 7 ml of medium. Cell growth was determined by measuring an optical density at 600 nm (OD.sub.600). In a 2-phase culture method for production of retinoid, 1 mL of dodecane (Cat. No. 297879, Sigma, USA) was placed on 5 ml of the culture medium.
(24) Conditions for Analysis of -Carotene and Retinoid
(25) -carotene and retinoid were extracted from bacteria cell pellets through acetone. In the 2-phase culture method including dodecane capping, cell pieces were completely removed by collecting a dodecane phase containing retinoid and centrifuging the same at 14,000 rpm for 10 minutes. The acetone extraction product and dodecane phase were analyzed using HPLC (LC-20A, Shimadzu, Kyoto, Japan) at detection wavelengths of 370 nm (retinal), 340 nm (retinol and retinyl acetate) and 454 nm (-carotene). The analysis was performed using a Symmetry C18 type (250 mm4.6 mm, 5 m) HPLC column including Sentry Guard C18 (15 mm4.6 mm, 5 m). A mobile phase of the column was each of methanol and acetonitrile in ratios of 95:5 and 70:30, respectively, for analyzing retinoid and -carotene. HPLC analysis was performed at a flow rate of 1.5 ml/min and a column temperature of 40 C. Retinal (Cat. No. R2500), retinol (Cat. No. R7632), retinyl acetate (Cat. No. R4632) and -carotene (Cat. No. C4582) were purchased from Sigma Co. (USA) and dissolved in acetone, respectively, to prepare standard compounds, and each of the prepared standard compounds was used. Through three independent experiments, results were obtained and represented by a meanSD.
Example 1: Preparation of Vector for Producing Escherichia coli with High Productivity of a -Carotene and Retinal
(26) Conventional processes involving genome DNA preparation, restriction enzyme cleavage, transformation and standard molecular biological technologies have been executed according to description in related documents (Sambrook and Russell 2001). PCR was performed using pfu DNA polymerase according to standard protocols (Solgent Co., Korea). blh gene of uncultured marine bacteria 66A03 (Genbank accession No. AAY68319) was synthesized into Genofocus (Daejeon, Korea) according to codon-optimization by Gene Designer software (DNA 2.0, Menlo Park, USA), in order to express the above gene in Escherichia coli.
(27) According to the present example, an enzyme involved in a velocity determination process, that is., a gene encoding DXP synthase was additionally introduced into Escherichia coli having an MEP path and, at the same time, a gene encoding an enzyme associated with a mevalonate path was selected from a variety of gene resources and introduced, thus preparing Escherichia coli with hugh productivity of -carotene.
(28) (1) Preparation of pSNA Vector Including a Gene Encoding an Enzyme in a Mevalonate Path Associated with Synthesis of IPP from a Carbon Source
(29) Genes encoding an enzyme in a mevalonate path associated with IPP synthesis from a carbon source used in the present experiment are shown in Table 1 below.
(30) TABLE-US-00001 TABLE 1 Gene sequence (Genbank Name of enzyme Gene accession No.) Acetyl-CoA mvaE SEQ. ID No. 18 acetyltransferase/hydroxymethylglytaryl (AF290092) (HMG)-CoA reductase derived from Enterococcus faecalis HMG-CoA synthase derived from mvaS SEQ. ID No. 19 Enterococcus faecalis (AF290092) Mevalonate kinase derived from mvaK1 SEQ. ID No. 20 Streptococcus pneumonia (AF290099) Phosphomevalonate kinase derived from mvaK2 SEQ. ID No. 21 Streptococcus pneumonia (AF290099) Mevalonate diphosphate decarboxylase mvaD SEQ. ID No. 22 derived from Streptococcus pneumoniae (AF290099) Isopentenyl diphosphate (IPP) isomerase Idi SEQ. ID No. 23 derived from Escherichia coli (U00096)
(31) Primers and restriction enzymes to amplify genes listed in Table 1 have been described.
(32) TABLE-US-00002 TABLE 2 Restriction Primer sequence enzyme mvaE F SEQ. ID No. 37 SacI R SEQ. ID No. 38 SmaI mvaS F SEQ. ID No. 39 SmaI R SEQ. ID No. 40 BamHI mvaK1, mvaK2, F SEQ. ID No. 41 KpnI mvaD R SEQ. ID No. 42 XbaI Idi F SEQ. ID No. 43 SmaI R SEQ. ID No. 44 SphI
(33) The primer sequences and restriction enzymes used in cloning the genes listed in Table 1 are stated in Table 2. Since mvaK1, mvaK2 and mvaD are present as a single operon in a chromosome, a whole operon rather than individual genes was subjected to PCR cloning at once.
(34) The genes listed in Table 1 were amplified using the primers listed in Table 3 through PCR which uses a chromosome DNA in each strain including corresponding gene as a matrix. The amplified product was introduced into pSTV28 vector (Takara Korea, Korea) (SEQ. ID No. 45) using the restriction enzymes listed in Table 2, thereby preparing the vector pSNA. The vector pSNA includes all of genes encoding the enzyme in a mevalonate path, which can produce IPP from acetyl-CoA.
(35) (2) Preparation of Vectors pT-HB and pT-DHB Including a Gene Encoding an Enzyme Associated with Synthesis of -Carotene from IPP
(36) Genes encoding an enzyme associated with synthesis of -carotene from IPP used in the present experiment, as well as DXP synthase gene as an enzyme involved in the velocity determination process in the MEP path, are shown in Table 3 below.
(37) TABLE-US-00003 TABLE 3 Gene sequence (Genbank Name of enzyme Gene accession No.) IPP isophomerase derived from ipiHpl SEQ. ID No. 24 Haematococcus pluvialis (AF082325) 1-deoxyxylolose-5-phosphate (DXP) dxs SEQ. ID No. 25 synthase derived from Escherichia coli (U00096) Geranylgeranyl pyrophosphate (GGPP) crtE SEQ. ID No. 26 synthase derived from pantoea agglomerans (M87280) Phytoene synthase derived from pantoea crtB SEQ. ID No. 27 agglomerans (M87280) Phytoene dehydrogenase derived from crtI SEQ. ID No. 28 pantoea agglomerans (M87280) Lycopene -cyclase derived from pantoea crtY SEQ. ID No. 29 ananatis (D90087)
(38) TABLE-US-00004 TABLE 4 Restriction Gene Primer sequence enzyme ipiHpl F SEQ. ID No. 46 SmaISphI R SEQ. ID No. 47 dxs F SEQ. ID No. 48 EcoR1SnaBI R SEQ. ID No. 49 crtE F SEQ. ID No. 50 BspHIEcoRI R SEQ. ID No. 51 crtB, crtI F SEQ. ID No. 52 EcoR1SacI R SEQ. ID No. 53 crtY F SEQ. ID No. 54 SalIPstI R SEQ. ID No. 55
(39) The primer sequences and restriction enzymes used in cloning the genes listed in Table 3 are stated in Table 4. Since crtB and crtl are present as a single operon in a chromosome, a whole operon rather than individual genes was subjected PCR cloning at once.
(40) The genes listed in Table 3 were amplified using the primers listed in Table 4 through PCR which uses a chromosome DNA in each strain including corresponding gene as a matrix. The amplified product was introduced into pTrc99A vector (Genbank accession No. M22744) (SEQ. ID No. 30) using the restriction enzymes listed in Table 4, thereby preparing the vector pT-DHB. The vector pTDHB includes all of genes encoding the enzyme associated with synthesis of -carotene from IPP, as well as DXP synthase (dxs) gene as an enzyme used in the velocity determination process in the MEP path. Further, among the genes listed in Table 3, all genes other than dxs were introduced into pTrc99A vector using the restriction enzymes listed in Table 4, thereby preparing the vector pT-HB.
(41) (3) Preparation of a Vector Including a Gene Encoding an Enzyme Associated with Synthesis of Retinal from -Carotene
(42) Genes encoding an enzyme associated with synthesis of retinal from -carotene used in the present experiment are shown in Table 5 below. As a gene encoding -carotene monooxygenase derived from uncultured marine bacterium 66A03, SR gene which is an Escherichia coli codon-optimized sequence of blh was used.
(43) TABLE-US-00005 TABLE 5 Gene sequence (Genbank Name of enzyme Gene accession No.) -carotene monooxygenase derived from blh SEQ. ID No. 31 uncultured marine bacterium 66A03 (DQ065755) -carotene monooxygenase derived from SR SEQ. ID No. 32 uncultured marine bacterium 66A03 (Escheri- chia coli codon- optimized sequence of blh) -carotene 15,15-monooxygenase BcmoI SEQ. ID No. 33 derived from Mus musculus (NM_021486) Brp-like protein 2 derived from brp2 SEQ. ID No. 34 Natronomonas pharaonis ATCC35678 (CR936257) -carotene monooxygenase derived from Blh SEQ. ID No. 35 Halobacterium salinarum ATCC700922 (AE004437) -carotene monooxygenase derived from Brp SEQ. ID No. 36 Halobacterium salinarum ATCC700922 (AE004437)
(44) TABLE-US-00006 TABLE 6 Restriction Gene Primer sequence enzyme SR F SEQ. ID No. 56 EcoR1SpeI R SEQ. ID No. 57 bcmo1 F SEQ. ID No. 58 EcoR1SpeI R SEQ. ID No. 59 brp2 F SEQ. ID No. 60 EcoR1SpeI R SEQ. ID No. 61 blh F SEQ. ID No. 62 EcoR1SpeI R SEQ. ID No. 63 brp F SEQ. ID No. 64 EcoR1SpeI R SEQ. ID No. 65
(45) The primer sequences and restriction enzymes used in cloning the genes listed in Table 5 are stated in Table 6. The genes listed in Table 5 were amplified using the primers listed in Table 6 through PCR which uses a chromosome DNA in each strain including a corresponding gene as a matrix. The amplified product was introduced into pT-HB vector using the restriction enzymes listed in Table 6, respectively, thereby preparing the vectors pT-HBSR, pT-HBBcmol, pT-HBbrp2, pT-HBblh and pT-HBbrp. Such vectors pT-HBSR, pT-HBBcmol, pT-HBbrp2, pT-HBblh and pT-HBbrp are vectors formed by introducing SR, Bcmol, brp2, blh and brp genes into pT-HB vector, respectively, and have included all of genes encoding an enzyme associated with the synthesis of retinal through -carotene from IPP. After cutting SR gene from pT-HBSR using Spel, the cut gene was introduced into a corresponding part of pT-DHB, thus preparing pT-DHBSR.
Example 2: Comparison of Different BCM(D)O Genes in Relation to Retinal Production
(46) Retinal may be produced by introduction of BCM(D)O gene encoding -carotene mono(di)oxygenase, which is a recombinant Escherichia coli producing -carotene. The present inventors have conducted cloning of BCM(D)O gene from two bacteria, i.e., Halobacterium sp NRC-1 (blh and brp genes) and Natronomonas pharaonis (brp2 gene), as well as Mus musculus (Bcmol gene) of a vertebrate animal. The present inventors have synthesized codon-optimized BCDO gene (SR) on the basis of an amino acid sequence of uncultured marine bacterium 66A03 blh gene. BCM(D)O gene (SR) was used to prepare retinal synthetic plasmids pT-HBblh, pT-HBbrp, pT-HBbrp2, pT-HBBcmol and pT-HBSR, respectively. The recombinant Escherichia coli cell containing each of retinal plasmids was cultured in a 2YT medium including 0.5% (w/v) of glycerol and 0.2% (w/v) of arabinose as a carbon source at 29 C. for 48 hours.
(47)
(48) As shown in
(49) For Escherichia coli including pT-HBblh or pT-HBbrp, a retinal productivity at 24 hours after culturing may be lower than a rate of degradation of the same. In the culture of Escherichia coli strain including pT-HBbrp2 or pT-HBBcmol, a trace amount of retinal was detected. Escherichia coli without BCM(D)O gene has produced 35 mg/L of -carotene, but did not produce retinal. Since -carotene is a precursor just before retinal, a -carotene consumption by BCM(D)O may be exactly proportional to the retinal productivity if there was retinal degradation. -carotene remained in a culture solution of Escherichia coli including BCM(D)O other than SR, therefore, -carotene cleavage activity of SR was expected to be the highest level among tested BCM(D)O. Accordingly, in an additional experiment, SR enzyme was adopted for retinal production. The cell growth did not come under the influence of over-expression of BCM(D)O gene except for N. pharaonis brp gene exhibiting delayed cell growth.
Example 3: Gene Manipulation into MEP and MVA Paths for Supplying a Building Block
(50) Retinal building blocks, that is, IPP and DMAPP may be synthesized in Escherichia coli through an inherent MEP path and a foreign MVA path (
(51) It was reported that synthesis of 1-deoxy-d-xylolose-5-phosphate (DXP) is an important velocity restriction process in the MEP path. Therefore, over-expression of DXP synthase (to be encoded by dxs) increased production of lycopene and -carotene in previous inventions of the present inventors. By introducing dxs gene into before the MEP path among pT-HBSR, pT-DHBSR was prepared.
(52)
(53) As shown in
Example 4: Effects of Escherichia Coli Strain, Culture Conditions and Carbon Source in Relation to Retinoid Production
(54) (1) Strain
(55) With regard to production of retinoid including retinal, retinol and retinyl acetate, effects of Escherichia coli strains were investigated. Five Escherichia coli strains including pT-DHBSR and pS-NA, that is, MG1655, DH5, XL1-Blue, S17-1 and BL21 (DE3) were used to produce retinoid. Table 7 shows characteristics of six Escherichia coli strains including the foregoing five strains.
(56) TABLE-US-00007 TABLE 7 E. coli strain Details MG1655 K12, wild type DH5 F.sup., f80dlacZM15, (lacZYA-argF)U169, deoR, recA1endA1, hsdR17(r.sub.K.sup.m.sub.K.sup.+), phoA, supE44, -, thi-1, gyrA96, relA1 XL1-Blue hsdR17, supE44, recA1, endA1, gyrA46, thi, relA1, lac/F'[proAB.sup.+, lacI.sup.q, lacZM15::Tn10(tet.sup.r)] S17-1 recA pro hsdR RP4-2-Tc::Mu-Km::Tn7 BL21 (DE3) F.sup., ompT, hsdS.sub.B(r.sub.B.sup.m.sub.B.sup.), gal(lcI857, ind1, Sam7, nin5, lacUV5-T7gene1), dcm(DE3) BW25113 (araD-araB)567, lacZ4787(::rrnB-3), lambda.sup., rph-1, (rhaD-rhaB)568, hsdR514
(57)
(58) As shown in
(59) (2) Culture Conditions
(60) With regard to production of retinoid, effects of dissolved oxygen were investigated with difference test volumes in a test tube having a diameter of 30 mm.
(61)
(62) As shown in
(63) Further, the retinoid production depending upon the temperature was investigated.
(64) As shown in
(65) (3) Carbon Source
(66) Effects of different carbon sources upon production of retinoid were compared.
(67)
(68) As shown in
(69) Next, effects of a concentration of glycerol upon the retinoid production and cell growth were investigated. Escherichia coli DH5(pT-DHBSR/pSNA) was grown in a 2YT medium including glycerol in a range of 0.0% to 2.0% (w/v), at 29 C.
(70)
(71)
(72) As shown in
(73) From all culture solutions, it was observed that the retinoid production was extremely reduced during stagnation of the cell growth, and this condition is deemed to be caused by discontinued production of retinoid during stagnation and intracellular oxidative degradation of the same.
(74) (4) Culture in the Presence of Dodecane
(75) Strains containing transformed pT-DHBSR/pSNA were used for six strains listed in Table 7. After adding 1 mL of dodecane to 5 ml of medium, culturing was conducted according to such conditions as described in bacteria strain and culture conditions. The medium used herein was a 2YT medium including 0.2% (w/v) of arabinose and 0.5% (w/v) of glycerol added thereto.
(76)
(77)
(78)
Example 5: 2-Phase Culture Using Dodecane for In-Situ Extraction of Retinoid
(79) In order to prevent intracellular degradation of retinoid, a 2-phase culture method was conducted using a hydrophobic solvent, that is, dodecane, in order to perform in-situ extraction of retinoid from cells. Dodecane was selected since it has a low toxicity to Escherichia coli I, a high hydrophobicity (log P.sub.o/w, 6.6) for extracting hydrophobic retinoid, and low volatile properties not to cause evaporation loss.
(80) In the present example, 1 mL of dodecane was added to 5 ml of culture solution.
(81) Retinoid was extracted into the dodecane phase while an insignificant amount of retinoid was detected in the culture solution and cell mass (data not shown). As a result, the retinoid productivity was measured from the dodecane phase. As shown in
(82) In order to investigate effects of the volume of dodecane addition on the retinoid production and cell growth, 1 mL to 5 mL of dodecane was initially added to a culture solution including 2% (w/v) of glycerol (
(83)
(84)
(85) As shown in
(86)
(87) The in-situ extraction of retinoid according to the present invention does not need lysozyme used for degrading a cell wall. Retinoid (C20, isoprenoid molecule) may be efficiently released from the cell without loss of the cell wall. In 2-phase culture for production of retinoid, -carotene must be continuously maintained in the cell since it is a direct precursor of the retinoid. If -carotene is extracted from the dodecane phase, it can be cut by BCD(M)O placed in cytosol.
(88) Due to a size of molecule, -carotene can neither be released from the cell nor extracted by dodecane, therefore, can be continuously maintained in the cell during 2-phase culture of -carotene (
(89)
(90) As shown in
(91) In the culture with addition of 5 mL of dodecane, a total 122 mg/L of retinoid productivity was attained at 48 hours. However, in the culture without addition of dodecane, only half of the above productivity (60 mg/L) was obtained at the same time period. Accordingly, the dodecane-added 2-phase culture system may be appropriately applied to an alternative transformation system to produce small lipophilic molecules.
Example 6: Production of Retinoid in Medium Including Lipophilic Substance
(92) The present example was performed to identify as to whether a variety of lipophilic substances have effects of increasing retinoid production.
(93) (1) Production of Retinoid in Medium Including Alkane
(94) A strain DH5 including transformed pT-DHBSR/pSNA (DH5(pT-DHBSR/pSNA)) was used, and after adding 5 mL of each of octane, decane, dodecane and tetradecane to 5 ml of medium, culturing was conducted according to such conditions as described in Bacteria strain and culture conditions. The medium used herein was a 2YT medium including 0.2% (w/v) of arabinose and 2.0% (w/v) of glycerol added thereto.
(95)
(96) As shown in
(97) (2) Production of Retinoid in Medium Including Mineral Oil
(98) (2.1) Lightweight Mineral Oil
(99) The lightweight mineral oil is cheap and has an economical advantage, as compared to alkanes. A strain DH5 including transformed pT-DHBSR/pSNA (DH5 (pT-DHBSR/pSNA)) was used, and after adding the lightweight mineral oil in different volumes to 5 ml of medium, respectively, culturing was conducted according to such conditions as described in Bacteria strain and culture conditions. The medium used herein was a 2YT medium including 0.2% (w/v) of arabinose and 2.0% (w/v) of glycerol added thereto.
(100)
(101) As shown in
(102)
(103) (2.2) Heavy Mineral Oil
(104) The heavy mineral oil is cheaper than the lightweight mineral oil. A strain DH5 including transformed pT-DHBSR/pSNA (DH5(pT-DHBSR/pSNA)) was used, and after adding 2 ml of heavy mineral oil to 5 ml of medium, culturing was conducted according to such conditions as described in Bacteria strain and culture conditions. The medium used herein was a 2YT medium including 0.2% (w/v) of arabinose and 2.0% (w/v) of glycerol added thereto.
(105)
(106) Except that a test tube was tilted and mounted on an incubator, cell culture was performed by the same procedures as described above. By tilting the test tube, effects of agitation were improved to thus allow the medium and mineral oil to be admixed more effectively.
(107)
(108) The above results indicated that mixing the lightweight and/or heavy mineral oils with the medium is an important factor in retinoid production since the mineral oils have a high viscosity. Accordingly, the foregoing lightweight and/or heavy mineral oils may be used for retinoid by properly agitating the same during culturing.
(109) (3) Production of Retinoid in Medium Including Skin-Friendly Lipophilic Substance
(110) Retinoid was produced in a medium including a skin-friendly lipophilic substance. As the skin-friendly lipophilic substance, isopropyl myristate (IPM), dioctanoyl-decanoyl glycerol (ODO), cetyl ethylhexanoate (CEH) and phytosqualane were used.
(111) A strain DH5 including transformed pT-DHBSR/pSNA (DH5(pT-DHBSR/pSNA)) was used, and after adding 2 ml of heavy mineral oil to 5 ml of medium, culturing was conducted according to such conditions as described in Bacteria strain and culture conditions. The medium used herein was a 2YT medium including 0.2% (w/v) of arabinose and 2.0% (w/v) of glycerol added thereto. A control was prepared by adding 5 mL of dodecane to the medium.
(112)